Metabolic and cardiovascular benefits with combination therapy of SGLT-2 inhibitors and GLP-1 receptor agonists in type 2 diabetes

doi:10.4330/wjc.v14.i6.329

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6765)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-4) series.

Item

Count

PDF

601

WORD

HTML

4240

Figures (1-5)

280

Tables (1-4)

251

Sum=5448

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

207

Download

427

Sum=634

Publishing Process of This Article

Item

Count

Browse

230

Download

453

Sum=683

Jun 26, 2022 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Opinion Review

World J Cardiol. Jun 26, 2022; 14(6): 329-342
Published online Jun 26, 2022. doi: 10.4330/wjc.v14.i6.329

Full Size Figure Download Figure

Figure 4 Heart failure hospitalization outcome with GLP-1 receptor agonist plus SGLT-2 inhibitor dual therapy or GLP-1 receptor agonists or SGLT-2 inhibitors vs placebo: A meta-analysis of two cardiovascular outcome trials.

Citation: Singh AK, Singh R. Metabolic and cardiovascular benefits with combination therapy of SGLT-2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. World J Cardiol 2022; 14(6): 329-342
URL: https://www.wjgnet.com/1949-8462/full/v14/i6/329.htm
DOI: https://dx.doi.org/10.4330/wjc.v14.i6.329